FdaApplication
BLA 125284
Identifiers
- fda_app_no: BLA125284
Properties
| Property | Value |
|---|---|
| applicant_name | rEVO Biologics, Inc. |
| application_type | BLA |
| approval_date | 2009-02-06 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ATRYN | — | 1750IU | For Injection |
| ATRYN | — | 525IU | For Injection |
2 products